Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brynn Everist

Allergy & Immunology Prairie Village, KS Medical Doctor

NPI 1093036832 CMS profile 593381

8340 Mission Rd Ste 212, Prairie Village, KS 66206

Open in the dashboard

General payments

$64,462

225 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brynn Everist of Prairie Village, KS is reported in the CMS Open Payments database as having received $64,462 across 225 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $60,051 102
2024 General $1,989 34
2023 General $952 29
2022 General $849 47
2021 General $533 12
2019 General $88 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brynn Everist
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Brynn Everist were reported at $60,051. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year Brynn Everist Allergy & Immunology median Middle half National median
2019 $88 $594 $163–$1,512 $163
2020 $0 $426 $106–$1,233 $114
2021 $533 $638 $157–$1,708 $132
2022 $849 $790 $205–$1,961 $149
2023 $952 $852 $220–$2,147 $160
2024 $1,989 $865 $203–$2,267 $164
2025 $60,051 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $60,789 97 payments
  2. AstraZeneca Pharmaceuticals LP $942 28 payments
  3. Regeneron Healthcare Solutions, Inc. $858 24 payments
  4. Amgen Inc. $314 18 payments
  5. GlaxoSmithKline, LLC. $286 12 payments
  6. Incyte Corporation $267 6 payments
  7. Blueprint Medicines Corporation $139 2 payments
  8. Novartis Pharmaceuticals Corporation $136 6 payments
  9. Aquestive Therapeutics, Inc. $119 1 payment
  10. Genentech USA, Inc. $106 6 payments
  11. Other $508 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,442 16 payments
  2. Travel and Lodging $8,062 12 payments
  3. Food and Beverage $5,978 193 payments
  4. Consulting Fee $893 2 payments
  5. Education $88 2 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $60,335 115 payments
  2. DUPIXENT Inflammation And Immunology $579 15 payments
  3. FASENRA $437 11 payments
  4. DUPIXENT Immunology And Inflammation $279 9 payments
  5. TEZSPIRE Inflammation $273 16 payments
  6. OPZELURA $267 6 payments
  7. NUCALA $164 9 payments
  8. AYVAKIT $139 2 payments
  9. TEZSPIRE Respiratory $129 5 payments
  10. LIBERVANT $119 1 payment
  11. Other $1,023 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

225 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record